Zobrazeno 1 - 10
of 38
pro vyhledávání: '"antibiotic-induced dysbiosis"'
Autor:
L. Clifford McDonald, Vincent B. Young, Mark H. Wilcox, Alison Laufer Halpin, Ricardo L. Chaves
Publikováno v:
mSphere, Vol 9, Iss 8 (2024)
ABSTRACT Although antibiotics remain a cornerstone of modern medicine, the issues of widespread antibiotic resistance and collateral damage to the microbiome from antibiotic use are driving a need for drug developers to consider more tailored, patien
Externí odkaz:
https://doaj.org/article/33b72f52e0354c29a9eb363ba2bf7d44
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 3-1, Pp 431-442 (2023)
Scientific relevance. A promising option for dysbiosis correction is the use of metabiotics, products based on metabolites of probiotic microorganisms. During fermentation, Bacillus subtilis bacteria (strains 3H and 1719) produce metabolites that exh
Externí odkaz:
https://doaj.org/article/e43f0fb51cec48c7a35d36e515c51a9e
Autor:
Stephen K. Costa, Katherine Antosca, Chapman N. Beekman, Rachel L. Peterson, Swathi Penumutchu, Peter Belenky
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT Antibiotic-induced gut microbiome dysbiosis (AID) is known to be influenced by host dietary composition. However, how and when diet modulates gut dysbiosis remains poorly characterized. Thus, here, we utilize a multi-omics approach to charac
Externí odkaz:
https://doaj.org/article/702e8597c5f9497e9ebb839e6ed0ce66
Autor:
C. Pirozzi, N. Opallo, L. Coretti, A. Lama, C. Annunziata, F. Comella, S. Melini, E. Buommino, M.P. Mollica, G. Aviello, G. Mattace Raso, F. Lembo, R. Meli
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 163, Iss , Pp 114860- (2023)
The antibiotic-induced intestinal injury (AIJ) is associated with diarrhoea and gastrointestinal discomfort. However, the pathological intestinal mechanisms and related side effects associated with antibiotic use/misuse may be counteracted by probiot
Externí odkaz:
https://doaj.org/article/82fb808dd251469f9d6feffb946c8d67
Autor:
Yu. Yu. Borschev, I. Yu. Burovenko, A. B. Karaseva, S. M. Minasyan, E. S. Protsak, V. Yu. Borschev, N. Yu. Semenova, O. V. Borshcheva, A. N. Suvorov, M. M. Galagudza
Publikováno v:
Медицинская иммунология, Vol 23, Iss 5, Pp 1089-1104 (2021)
Overweight and obesity are among the main factors of cardiovascular risk, but the prospective studies on the dependence between high-fat diets and weight gain yielded contradictory results. Different types of fats exert varying metabolic effects, and
Externí odkaz:
https://doaj.org/article/87e0c17a0df143e5973e3e3ada088914
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yu. Yu. Borschev, I. Yu. Burovenko, A. B. Karaseva, S. M. Minasyan, V. Yu. Borschev, N. Yu. Semenova, O. V. Borshcheva, V. V. Polovinkin, G. G. Rodionov, A. N. Suvorov, M. M. Galagudza
Publikováno v:
Медицинская иммунология, Vol 22, Iss 1, Pp 87-98 (2020)
Our objective was to develop a model of systemic inflammatory response syndrome (SIRS) by chemical induction of colon injury and antibiotic-associated intestinal dysbiosis in rats with primary visceral obesity (PVO) for studies of myocardial resistan
Externí odkaz:
https://doaj.org/article/b7f93259c7ce4f4698434544cdc32012
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alisa Arslanova, Aksiniya Tarasova, Anastasia Alexandrova, Vera Novoselova, Ilnar Shaidullov, Dilyara Khusnutdinova, Tatiana Grigoryeva, Dina Yarullina, Olga Yakovleva, Guzel Sitdikova
Publikováno v:
Life, Vol 11, Iss 8, p 764 (2021)
Accumulating clinical and preclinical data indicate a prominent role of gut microbiota in regulation of physiological functions. The gut-brain axis imbalance due to gut dysbiosis is associated with a range of neurodegenerative diseases. Probiotics we
Externí odkaz:
https://doaj.org/article/359f43e6f192440faf9421b4a05a40e7
Autor:
Min Jung Geum, Chungsoo Kim, Ji Eun Kang, Jae Hee Choi, Jae Song Kim, Eun Sun Son, Sun Min Lim, Sandy Jeong Rhie
Publikováno v:
Pharmaceuticals, Vol 14, Iss 5, p 445 (2021)
Antibiotic-induced dysbiosis may affect the efficacy of immune checkpoint inhibitors. We investigated the impact of antibiotics on the clinical outcomes of nivolumab in patients with non-small cell lung cancer (NSCLC). Patients who received nivolumab
Externí odkaz:
https://doaj.org/article/d12b41ea856d45ff8cd93e8ff58c30f4